Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In accordance with Article 5(2) of Directive 2001/83/EC on the Community Code relating to Medicinal Products for Human Use, in response to the confirmed spread of influenza virus the Secretary of State for Health has temporarily authorised the distribution of unlicensed oseltamivir powder and an unlicensed oral liquid formulation of oseltamivir for administration to infants under 1 year of age in the prevention or treatment of influenza. The Medicines for Human Use (Marketing Authorisations Etc) Regulations 1994 and the Medicines for Human Use (Manufacturing, Wholesale Dealing and Miscellaneous Amendments) Regulations 2005 have been amended.
